VRCA - Verrica Pharmaceuticals Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
4.1 -0.08 (-1.95%) --- --- 0.0 (0.0%) -0.1 (-2.38%) 0.04 (0.99%) 0.0 (0.0%) 0.0 (0.0%)

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
0.02
Diluted EPS:
0.02
Basic P/E:
201.0
Diluted P/E:
201.0
RSI(14) 1m:
0.0
VWAP:
4.02
RVol:
0.0984

Events

Period Kind Movement Occurred At

Related News